Literature DB >> 2995433

Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III).

M C Sirianni, P Rossi, B Scarpati, G Ragona, R Seminara, G Bonomo, F Aiuti.   

Abstract

Thirteen patients affected with unexplained lymphoadenopathy, fever, weight loss, and diarrhea (lymphoadenopathy syndrome; LAS) were evaluated for the possible appearance of acquired immunodeficiency syndrome (AIDS) and for immunological and virological characterization. The patients belonged to categories of individuals at risk for AIDS and were homosexual and/or drug abusers or hemophiliacs. Lymph node biopsy showed the histological picture of a follicular hyperplasia. The study of cell-mediated immunity (CMI), humoral immune response, and natural killer (NK) activity demonstrated a significant decrease in T cells with the helper/inducer phenotype (OKT4+ cells) and a relatively increased number of lymphocytes with the suppressor/cytotoxic phenotype (OKT8+ cells). NK activity was significantly lower than in normal controls. The in vitro response to polyclonal activators (phytohemagglutinin; PHA) and the cutaneous responsiveness to recall skin tests were impaired, whereas immunoglobulin production was increased, mainly in the IgG fraction. Virological studies showed high serum antibody titers to cytomegalovirus (CMV) but a lack of specific CMI as assayed by the leukocyte migration inhibition test (LMIT). CMV was also isolated from the urine specimen of one patient. The antibody pattern to Epstein-Barr virus (EBV) showed the uncommon contemporary presence of both Epstein-Barr nuclear antigen (EBNA) and early antigen (EA) antibodies. Antibodies to human T-lymphotropic retroviruses (HTLV III) were positive in 10 patients and the virus was isolated in 3 of them. In some patients the presence of serum antibodies to HTLV III was not associated with an impairment of the immune function. A group of individuals at risk for AIDS without LAS was also evaluated for the presence of HTLV III antibodies; the percentage of positive sera was 11.4.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995433     DOI: 10.1007/bf00929461

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  In vitro transfer of specific reactivity to cytomegalovirus and candida to cord blood leukocytes with dialyzable leukocyte extracts.

Authors:  M C Sirianni; M Fiorilli; A Paná; M Pezzella; F Aiuti
Journal:  Clin Immunol Immunopathol       Date:  1979-11

2.  Cell-mediated immunity in human cytomegalovirus infection.

Authors:  M Fiorilli; M C Sirianni; P Iannetti; A Panà; M Divizia; F Aiuti
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

3.  Studies in homosexual patients with and without lymphadenopathy. Relationships to the acquired immune deficiency syndrome.

Authors:  R D deShazo; J P Penico; G A Pankey; J A Nordberg; J L Newton; B Bozelka; L M Cortez; J R Dalovisio
Journal:  Arch Intern Med       Date:  1984-06

4.  Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

Authors:  B Safai; M G Sarngadharan; J E Groopman; K Arnett; M Popovic; A Sliski; J Schüpbach; R C Gallo
Journal:  Lancet       Date:  1984-06-30       Impact factor: 79.321

5.  Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS.

Authors:  E Vilmer; F Barre-Sinoussi; C Rouzioux; C Gazengel; F V Brun; C Dauguet; A Fischer; P Manigne; J C Chermann; C Griscelli
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

6.  Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions.

Authors:  F P Siegal; C Lopez; G S Hammer; A E Brown; S J Kornfeld; J Gold; J Hassett; S Z Hirschman; C Cunningham-Rundles; B R Adelsberg
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

7.  Severe combined immunodeficiencies, primary T-cell defects and DiGeorge syndrome in humans: characterization by monoclonal antibodies and natural killer cell activity.

Authors:  M C Sirianni; L Businco; R Seminara; F Aiuti
Journal:  Clin Immunol Immunopathol       Date:  1983-09

8.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.

Authors:  J F Sheridan; L Aurelian
Journal:  Diagn Immunol       Date:  1983
View more
  1 in total

1.  Persistent nonproductive infection of Epstein-Barr virus-transformed human B lymphocytes by human immunodeficiency virus type 1.

Authors:  K E Dahl; T Burrage; F Jones; G Miller
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.